·ETF Intelligence

ETF · Exchange Traded Fund

ARKG

ARK Genomic Revolution ETF

$33.47

↓0.18(0.53%)

Total Assets

$1.3B

Expense Ratio

—

Holdings

Top 20 shown

What is this ETF?

ARK Genomic Revolution ETF. Cathie Wood active fund betting on biotech, gene editing, and health innovation. Very high risk, very high volatility.

What themes are you invested in?

Through ARKG, you have exposure to these market themes.

Pharmaceuticals & Biotech

CRSP 9.1%BEAM 6.8%NTLA 6.2%EXAS 4.3%

26.4%

of ETF

Gene Editing & Genomics

CRSP 9.1%BEAM 6.8%NTLA 6.2%EXAS 4.3%

26.4%

of ETF

Healthcare Services

TDOC 3.5%

3.5%

of ETF

Companies we cover in this ETF

Click any to read the full plain-English research.

CRSP

9.1% of ETF

BEAM

6.8% of ETF

NTLA

6.2% of ETF

EXAS

4.3% of ETF

TDOC

3.5% of ETF

Top 20 holdings

CRSPCRISPR Therapeutics

9.1%

RXRXRecursion Pharma

8.3%

TWSTTwist Bioscience

7.2%

BEAMBeam Therapeutics

6.8%

NTLAIntellia Therapeutics

6.2%

PACBPacific Biosciences

5.9%

FATEFate Therapeutics

5.1%

VCYTVeracyte

4.7%

EXASExact Sciences

4.3%

IRDMIridium Communications

3.9%

TDOCTeladoc Health

3.5%

ACCDAccolade

3.1%

NVTAInvitae

2.8%

ARWRArrowhead Pharma

2.5%

IONSIonis Pharma

2.2%

VERVVerve Therapeutics

2.0%

OMEROmeros Corp

1.8%

PRMEPrime Medicine

1.6%

GRAILGRAIL Inc

1.4%

MASS908 Devices

1.2%

Sector breakdown

Healthcare

100%